KFF Health News

Encuesta revela que persiste la discriminación racial en la atención médica

Muchas personas de grupos raciales y étnicos minoritarios dicen que se preparan mentalmente para recibir insultos y ser prejuzgados antes de las citas médicas, según una nueva encuesta entre pacientes que reafirma la prevalencia de la discriminación racial en el sistema de salud de Estados Unidos.

La encuesta de KFF, que se realizó con casi 6,300 pacientes que han estado recibiendo atención en los últimos tres años, encontró que alrededor del 55% de los adultos de raza negra sienten que deben tener mucho cuidado con su apariencia para ser tratados de manera justa por los médicos y otros proveedores de atención de salud.

Casi la mitad de los pacientes hispanos, los Indio americanos y los nativos de Alaska sienten lo mismo, al igual que aproximadamente 4 de cada 10 pacientes asiáticos.

En comparación, el 29% de los blancos no hispanos encuestados dijeron que se preocupaban por su apariencia antes de las citas.

“En 2023, la noción de que cualquier persona debe prepararse para sufrir discriminación es triste por un lado y enojoso por el otro”, dijo Burgess Harrison, director ejecutivo de la National Minority Health Association, en un correo electrónico . “El estrés que causa, además de cualquier problema de salud involucrado… es una locura”.

La discriminación ha sido durante mucho tiempo una preocupación tanto para los pacientes como para los proveedores de atención médica, en un país en donde las disparidades raciales en los resultados de salud son enormes y particularmente desfavorables para las personas negras.

Un hombre hispano de 30 años de Illinois, que respondió a la encuesta de KFF, dijo a los investigadores que cuando va a sus citas médicas usa ropa con el logo de la universidad en donde trabaja. Se dio cuenta que cuando los proveedores se enteran que es profesor, lo escuchan más atentamente y lo involucran más en las decisiones médicas, dijo.

Una mujer asiática de 44 años de California dijo que sus médicos varones, blancos no hispanos, ignoraron sus preocupaciones sobre sus problemas respiratorios y le dijeron que “probablemente estaba pensando demasiado en respirar”. Más tarde le diagnosticaron asma.

Los dos encuestados no fueron identificados con nombre y apellido en el estudio.

La encuesta ofrece “una manera de cuantificar realmente cuáles son esas experiencias con el racismo y la discriminación, y las múltiples formas en las que luego impactan en la vida de las personas”, dijo Samantha Artiga, directora del programa de políticas de salud y equidad racial de KFF.

“Para las personas que han estado siguiendo estos temas durante mucho tiempo, los hallazgos no son inesperados”, agregó. Otros hallazgos del sondeo fueron:

  • Un tercio de los adultos informaron al menos una de varias experiencias negativas con un proveedor de atención médica en los últimos tres años, como que un profesional asumiera algo sobre ellos sin preguntar, o sugiriera que ellos eran los responsables de su problema de salud.
  • Casi una cuarta parte de los adultos negros, el 19% de los adultos nativos de Alaska y nativos americanos, el 15% de los adultos hispanos y el 11% de los adultos asiáticos dijeron que creían que habían sufrido un trato negativo debido a su raza u origen étnico.
  • El 22% de las embarazadas o que dieron a luz en los últimos 10 años, de raza negra, dijeron que les negaron los analgésicos que pensaban necesitaban. Sólo el 10% de los adultos blancos no hispanos en circunstancias similares informaron la misma queja.

Cuando las personas no se sienten respetadas o bienvenidas por sus proveedores de salud, es posible que eso los desanime a buscar ayuda médica o que cambien de proveedor con más frecuencia, dijo Artiga. Los pacientes de poblaciones minoritarias “experimentan peor salud como resultado de un trato injusto en el sistema de atención médica”, agregó.

La encuesta también encontró que la discriminación fuera del sistema de atención médica tenía consecuencias para la salud. Las personas que dijeron haber experimentado discriminación en su vida cotidiana informaron dos veces más seguido que a menudo se sentían ansiosas, solas o deprimidas en comparación con aquellas que rara vez o nunca habían enfrentado discriminación.

La encuesta encontró que las personas negras que reportaron tonos de piel más oscuros tenían más probabilidades de haber sufrido discriminación que aquellos con piel más clara. También reveló “cómo persisten y prevalecen las experiencias de racismo y discriminación hoy en día, en la vida diaria y también en la atención médica, a pesar del aumento de las alertas y el abordaje sobre el racismo”, dijo Liz Hamel, directora de investigación de encuestas y opinión pública de KFF.

La diversidad entre los proveedores de atención médica es importante, según la encuesta. La mayoría de las personas de minorías que participaron en la encuesta dijeron que menos de la mitad de sus visitas médicas en los últimos tres años fueron con un proveedor de su misma raza u origen étnico. Los que sí vieron a un médico de su misma raza o etnia tuvieron más probabilidades de informar mejores experiencias, como que su médico les explicara las cosas “de una manera que pudieran entender” o les preguntara sobre otros factores de salud como su empleo, vivienda y acceso a alimentos y transporte.

El 40% de los adultos negros que vieron a proveedores de su mi raza reportaron haber discutido temas sociales y económicos, mientras que solo el 24% dijo haber charlado sobre estos temas con proveedores de otras razas.

​Harrison, de la National Minority Health Association, escribió que “es vital un énfasis renovado en reclutar más personas de color en el campo de la atención médica”.

Agregó que la encuesta “ilustra dolorosamente que el prejuicio racial en la atención sanitaria es tan dañino como cualquier enfermedad”.

La “Encuesta sobre racismo, discriminación y salud” de KFF se realizó del 6 de junio al 14 de agosto en línea y por teléfono entre una muestra representativa a nivel nacional de adultos estadounidenses en inglés, español, chino, coreano y vietnamita.

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

USE OUR CONTENT

This story can be republished for free (details).

1 year 4 months ago

Health Industry, Noticias En Español, Race and Health, california, Disparities, Illinois, KFF, Latinos, Polls

Health and Science

AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion

The deal is AbbVie's latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic competition.

The deal is AbbVie's latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic competition.

1 year 4 months ago

STAT

Eli Lilly’s latest $1.4 billion deal might come unglued

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning, everyone. Damian here with another multibillion-dollar deal, a word on the future of Sanofi, and a setback in one of medicine’s longest-running quests.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning, everyone. Damian here with another multibillion-dollar deal, a word on the future of Sanofi, and a setback in one of medicine’s longest-running quests.

Read the rest…

1 year 4 months ago

Biotech, Business, Health, Pharma, Politics, The Readout, biotechnology, drug development, drug prices, drug pricing, finance, Pharmaceuticals, Research, vaccines

STAT

STAT+: Pharmalittle: White House takes aim at pharma patents to lower drug prices; Sanofi CEO defends reducing earnings forecast

Top of the morning to you. Gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will trot out a bit of insight from the Morning Mayor, who would say, “Every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and invite you to join us.

Remember, a prescription is not required. So no need to mess with rebates. Our choice today is chocolate raspberry. Meanwhile, here are a few items of interest. Hope you have a smashing day and, of course, do stay in touch. …

The White House is throwing its support behind a controversial authority that allows the government to claw back patents for certain high-priced medicines, STAT tells us. The move is an early step that could have major ramifications for the pharmaceutical industry, depending on whether and how federal officials actually use the authority. The administration will issue a framework for the U.S. National Institutes of Health to more broadly use march-in rights, a policy that allows it to seize patents from drugmakers whose products rely on federally funded research. The framework will detail when the agency might assert this authority, and endorse using drug prices when deciding.

AbbVie announced plans to purchase Cerevel Therapeutics and its pipeline of experimental neurological and psychiatric medications for $8.7 billion, STAT writes. The deal marks the second billion-dollar acquisition by AbbVie in under a week. Facing the prospect of declining sales from two of its best-selling drugs, the company also acquired Immunogen and its ovarian cancer treatment for $10 billion last week. With this latest deal, AbbVie will acquire several clinical-stage molecules for Parkinson’s, schizophrenia, and epilepsy, among other disorders, many of which previously belonged to one of its biggest rivals.

Continue to STAT+ to read the full story…

1 year 4 months ago

Pharma, Pharmalot, pharmalittle, STAT+

Health – Caribbean News Service

IAS calls for stepping up HIV vaccine R&D after PrEPVacc halts its vaccine arm

PrEPVacc announced today that it “has stopped further vaccinations as there is little or no chance of the trial demonstrating vaccine efficacy in preventing HIV acquisition”. Its pre-exposure prophylaxis (PrEP) trial is set to continue. While IAS – the International AIDS Society – is disappointed at this outcome, we believe that this provides us with lessons to drive HIV […]

PrEPVacc announced today that it “has stopped further vaccinations as there is little or no chance of the trial demonstrating vaccine efficacy in preventing HIV acquisition”. Its pre-exposure prophylaxis (PrEP) trial is set to continue. While IAS – the International AIDS Society – is disappointed at this outcome, we believe that this provides us with lessons to drive HIV […]

1 year 4 months ago

Caribbean News, Health

STAT

STAT+: AbbVie purchases neuroscience developer Cerevel for $8.7 billion

Abbvie announced Wednesday that it will purchase Cerevel Therapeutics and its pipeline of experimental neurological and psychiatric medications for $8.7 billion.

The deal marks the second billion-dollar acquisition by AbbVie in under a week. Facing the prospect of declining sales from two of its best-selling drugs, the company also acquired Immunogen and its ovarian cancer treatment for $10 billion last Thursday.

With the buyout, AbbVie will acquire several clinical-stage molecules for Parkinson’s, schizophrenia, and epilepsy, among other disorders, many of which previously belonged to one of the company’s biggest rivals.

Continue to STAT+ to read the full story…

1 year 4 months ago

Biotech, AbbVie, biotechnology, STAT+

STAT

Most drugmakers have so far ignored looming FTC deadline to withdraw or amend wayward patents

With 10 days to go, only one company has responded to a demand by the U.S.

With 10 days to go, only one company has responded to a demand by the U.S. Federal Trade Commission for several brand-name drugmakers to delist dozens of patents that were improperly or inaccurately listed in a government registry, according to a source familiar with the matter.

As a result, the agency is readying plans to file lawsuits against the other companies, some of which are among the biggest drugmakers in the world, such as AbbVie, AstraZeneca, and GSK. The FTC notified the companies on Nov. 7 that they must withdraw or amend the patent listings, or an individual must certify under penalty of perjury that the listings comply with federal law and regulations.

Read the rest…

1 year 4 months ago

Pharma, Pharmalot, FTC, patents, Pharmaceuticals

PAHO/WHO | Pan American Health Organization

En visita a Uruguay, Director de OPS se reunió con altas autoridades y destacó fortalezas del sistema de salud del país

PAHO Director meets with high-level authorities in Uruguay, highlights strengths of country's health system

Cristina Mitchell

6 Dec 2023

PAHO Director meets with high-level authorities in Uruguay, highlights strengths of country's health system

Cristina Mitchell

6 Dec 2023

1 year 4 months ago

PAHO/WHO | Pan American Health Organization

WHO calls on countries to increase taxes on alcohol and sugary sweetened beverages

WHO calls on countries to increase taxes on alcohol and sugary sweetened beverages

Cristina Mitchell

6 Dec 2023

WHO calls on countries to increase taxes on alcohol and sugary sweetened beverages

Cristina Mitchell

6 Dec 2023

1 year 4 months ago

Health

How do phytonutrients promote health?

PHYTONUTRIENTS ARE natural compounds found in plant foods such as vegetables, fruit, wholegrain products and legumes. These plant compounds have beneficial effects working with other essential nutrients to promote good health. Phytonutient...

PHYTONUTRIENTS ARE natural compounds found in plant foods such as vegetables, fruit, wholegrain products and legumes. These plant compounds have beneficial effects working with other essential nutrients to promote good health. Phytonutient...

1 year 4 months ago

Health

What is balanced nutrition?

EATING A healthy, balanced diet is an important part of maintaining good health, and can help you feel your best. This means eating a wide variety of foods in the right proportions, and consuming the right amount of food and drink to achieve and...

EATING A healthy, balanced diet is an important part of maintaining good health, and can help you feel your best. This means eating a wide variety of foods in the right proportions, and consuming the right amount of food and drink to achieve and...

1 year 4 months ago

PAHO/WHO | Pan American Health Organization

At COP28, PAHO Assistant Director calls for regional solidarity to address health impacts of “triple planetary crisis” of climate change, biodiversity loss, and pollution

At COP28, PAHO Assistant Director calls for regional solidarity to address health impacts of “triple planetary crisis” of climate change, biodiversity loss, and pollution

Cristina Mitchell

5 Dec 2023

At COP28, PAHO Assistant Director calls for regional solidarity to address health impacts of “triple planetary crisis” of climate change, biodiversity loss, and pollution

Cristina Mitchell

5 Dec 2023

1 year 4 months ago

Health News Today on Fox News

California woman with painful fat deposit disorder gets ‘life-changing’ surgery, has ‘newfound freedom’

An estimated one in nine adult women struggle with an abnormal and painful fat buildup in the lower body — and no amount of diet or exercise can help.

An estimated one in nine adult women struggle with an abnormal and painful fat buildup in the lower body — and no amount of diet or exercise can help.

Lipedema, a relatively common but often overlooked disease, causes fat to accumulate in the lower part of the body, primarily the butt, thighs and calves. 

For many women, like Molly Friar, an event planner in Sacramento, California, it can cause debilitating pain and impaired mobility.

In an effort to raise awareness of this condition, Friar, 53, spoke with Fox News Digital about her long journey to diagnosis — and what she calls her newfound "freedom."

HIDDEN BELLY FAT COULD SIGNAL ALZHEIMER’S DISEASE RISK 15 YEARS BEFORE SYMPTOMS SHOW UP, STUDY FINDS

Friar was just 11 years old when she started to notice that her body was different than everyone else’s, she said during a phone interview.

"The lipedema itself is governed by hormone changes, so that's when things really took off for me," she said. "My legs were different from every other girl in my class, and I started to get a bit of a stomach in my lower abdomen."

It was puzzling for Friar, who was very fit and athletic. 

She played soccer, basketball and softball, and was also a cheerleader — yet no matter how active she was or how carefully she ate, her lower body carried an abnormal amount of fat.

"Somehow my legs and stomach were always disproportionately bigger than everybody else's," she said.

BREAST CANCER SURVIVOR SAYS HER 120-POUND WEIGHT LOSS HELPED SAVE HER LIFE: 'STRONG, CONFIDENT AND HEALTHY'

Adding complexity to the situation, Friar is adopted — so she had no context that might have predicted this genetic condition.

"I don't have pictures of my family to look at, to see a grandmother or an aunt or other women in my life that were affected by it," she said.

Friar felt "completely out of place," she said, as everyone else in her family was "super skinny" and she was not.

Friar was just 12 years old when her parents put her on a Weight Watchers program.

"They felt like that was the best thing they could do to help me," she said. 

Throughout her adolescence and young adulthood, Friar worked out every day, biking to the gym and taking aerobics with all the adults.

"That’s absolutely where I started a battle of shame around my body — something I couldn't control," she said. 

"I would eat less or not eat, and exercise more, and do all the things I could think of to outpace something that I didn't know existed."

She added, "I always felt like there was a person inside of me who was thin and just wanted to get out."

In addition to the body image struggles, Friar’s condition also came with extreme pain.

EXPERIMENTAL WEIGHT LOSS DRUG COULD HELP TREAT FATTY LIVER DISEASE IN PEOPLE WITH OBESITY, STUDY FINDS

Lipedema causes inflammation and extreme bruising — "I would just brush up against something and get a bruise," said Friar.

The activities that were pleasant for other people, like getting a massage during a pedicure, created "excruciating pain" for Friar.

For someone with lipedema, she explained, running a hand over the skin is like touching a rocky beach — "you can feel the nodules like pebbles under the skin."

Other common symptoms include swelling, a feeling of heaviness in the legs and excess fatigue. 

For some patients, the condition can cause difficulty walking, heightened anxiety and depression, joint issues, venous (vein) disease and other complications, according to Cleveland Clinic.

In 2016, when Friar was 45 years old, she lost 50 pounds — but didn’t lose a centimeter in her calves.

She started digging in to figure out what was going on. "I knew something wasn’t right," she said.

In her online research, it wasn’t long before Friar was looking at photos of women with lipedema, with abnormal fat deposits in their lower bodies.

"In that moment, I cried — it was like looking in a mirror," she told Fox News Digital. 

"I felt validated and relieved and ecstatic — I finally had an answer."

But the relief was short-lived, as Friar quickly realized there was no cure for her condition. "It’s something that you have to try to battle for the rest of your life."

There are, however, options to alleviate some symptoms that come with lipedema, as Friar found out when she began seeing her doctor, Jaime S. Schwartz, M.D., in Beverly Hills, California.

A board-certified plastic surgeon and world-renowned lipedema specialist, Schwartz has dedicated much of his career to raising awareness for fat disorders like lipedema.

He launched Total Lipedema Care to help women like Friar.

"Most people will tell you that the lower half of their body just started growing a lot larger than the upper half, usually during puberty," Schwartz told Fox News Digital.

"It doesn't start as pain, but they start seeing physical changes that don’t really make sense."

Lipedema is usually misdiagnosed as morbid obesity, Schwartz noted.

"In the U.S., many doctors tell women, ‘You're fat, you did this to yourself,’" he said.

MORE THAN HALF THE WORLD'S POPULATION WILL BE OBESE OR OVERWEIGHT BY 2035, SAYS NEW REPORT

But the good news, he said, is that awareness is slowly starting to grow.

"Over the past five years, it's gone from no one knowing about it to a lot of people knowing about it, so it's definitely getting better."

As Schwartz told Friar, he recommends surgery as the best option to relieve lipedema symptoms.

At his practice, Schwartz performs a patented procedure called manual lipedema extraction, which involves a combination of liposuction and the removal of underlying nodules of fat through small incisions.

"When I take the ‘bad tissue’ out, people feel better as soon as the next day," Schwartz said. "That's the only thing that I've seen that works — and I've seen everything that's out there."

Friar ended up having a total of three surgeries — one on the back of her legs, one in the stomach area and one on the front of her legs.

"For me, the surgery was life-changing," Friar said. "I feel it changed the game for me — it extended my life and I gained back probably 75% to 80% of my mobility."

Each surgery required around six weeks of recovery time.

"It isn’t easy, but I would do it 1,000 times over," she said.

One caveat is that some insurance companies have been slow to cover the cost of lipedema surgeries. Friar had to pay out of pocket for the procedures, which can range from $4,000 to $16,000, according to Schwartz's website.

"I was very, very lucky — there are so many women who want the surgery that can't afford it," she said.

In addition to the surgeries, dietary changes have had a big impact on Friar’s quality of life.

"The optimal diet for me is gluten-free and dairy-free, with no added sugars, no processed foods, low salt and very little alcohol," she said.

She also wears medical-grade compression gear at night and lighter-compression leggings during the day.

"It helps alleviate a lot of the inflammation and excess fluid in the body," she said.

Other non-surgical options for relief include exercise and medications or supplements to reduce inflammation.

10 FUNCTIONAL HEALTH PREDICTIONS FOR 2024, ACCORDING TO A DOCTOR AND A WELLNESS EXPERT

As Schwartz told Fox News Digital, Friar’s case was pretty typical of most women’s experiences with lipedema, although he noted her positive mindset.

"A lot of women have had this for so long, and it defeats them emotionally, psychologically and mentally," he said. "But Molly has always had such an amazing outlook and personality."

He added, "Obviously, it's been emotional for her at times, but she never let it defeat her."

Friar said her life now is "like night and day" compared to before.

"Getting a massage for me is now enjoyable," she said through tears. "I can climb to the top of a mountain, and I can walk six miles and not stop."

"It’s like your mobility gets taken away from you, and when you instantly get it back, it's newfound freedom."

Friar’s goal is to increase awareness around this condition, among patients and doctors alike, so other women don’t have to live in shame for years like she did.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"It’s something we need to be talking about," she said. "It’s such a visual thing, involving our bodies and how we present ourselves to the world, and it’s something we can’t control."

"I'm willing to shout from the rooftops if I can help even one person recognize the symptoms and be able to help themselves."

For many of Schwartz’s patients, he said, the disease has "destroyed their lives."

"They don't go out, they don't socialize, they're afraid to work or wear certain clothes in public," he said.

Some women can't have their grandchildren sit on their lap or can't hold their spouse's hand because it’s too painful, he said. 

"So when they have surgery and they're not in pain, not only do they look different and they're so happy to rediscover their body, but they can even have their dog sit in their lap for the first time," he said.

"It’s a very overwhelming reality for them in a beautiful way," he also said.

It is estimated that around 11% of women are living with lipedema today.

For more Health articles, visit www.foxnews.com/health.

1 year 4 months ago

Health, Obesity, pain-management, lifestyle, Surgery, california, womens-health

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Back versus chest ECG electrode placement: Preset back ECG electrodes promising in neonates requiring advanced resuscitation

USA: A pilot randomized controlled trial published in Resuscitation has shown encouraging results of preset-back ECG electrodes, attached to the back of the newborn, in neonates requiring advanced resuscitation.

USA: A pilot randomized controlled trial published in Resuscitation has shown encouraging results of preset-back ECG electrodes, attached to the back of the newborn, in neonates requiring advanced resuscitation.

The recent Neonatal Resuscitation Program recommends the early utilization of an ECG (electrocardiogram) for non-vigorous newborns in the delivery room. However, placing ECG electrodes on the chest may delay obtaining a reliable heart rate and could interfere with chest compressions. A previous study showed that preset ECG electrodes are quicker than a pulse oximeter (POX) for heart rate detection.

Rashmi Gulati, University of South Alabama Children’s and Women’s Hospital, AL, USA, and colleagues aimed to compare time to detect a reliable HR using back-placed ECG electrodes versus standard front placement.

For the study, infants were randomly assigned to back (n = 85) or chest (n = 89) electrode placement. Time measurement began upon placing infants on a Panda warmer ResusView. Failure was defined as no heart rate detected within 5 minutes. The intention-to-treat analysis compared HR signal acquisition time between groups.

Based on the study, the researchers reported the following findings:

· Both groups showed similar proportions of detectable HR within the first minute.

· Median time to obtain HR was 26 seconds for the chest group and 21 seconds for the back group.

· A large number of vigorous infants were included. In the chest group, these vigorous infants had shorter HR acquisition times than non-vigorous infants (Mean ± SD of 34 ± 48 seconds vs. 50 ± 44 seconds respectively).

· Failure rates and time to acquire an HR for infants who were non-vigorous and required advanced resuscitation were similar between the back and chest groups.

"Preset back ECG electrodes have shown encouraging results in neonates requiring advanced resuscitation," the researchers wrote. "There is a need for further studies to enhance guidance during neonatal resuscitation."

Reference:

Gulati R, Sayegh L, McCurley C, Eyal F, Zayek M. Back vs. chest ECG electrode placement in neonatal resuscitation: A pilot randomized controlled trial. Resuscitation. 2023 Nov;192:109961. doi 10.1016/j.resuscitation.2023.109961. Epub 2023 Sep 9. PMID: 37678627.

1 year 4 months ago

Anesthesia,Pediatrics and Neonatology,Anesthesia News,Pediatrics and Neonatology News,Top Medical News,Latest Medical News

Health | NOW Grenada

2024 Budget Statement

Presented by Honourable Dennis Cornwall, Minister for Finance

View the full post 2024 Budget Statement on NOW Grenada.

Presented by Honourable Dennis Cornwall, Minister for Finance

View the full post 2024 Budget Statement on NOW Grenada.

1 year 4 months ago

Business, Education, Environment, Health, Politics, Technology, Video, Youth, budget presentation, dennis corwall, parliament, revenue and expenditure

PAHO/WHO | Pan American Health Organization

La OPS, el BID y el Banco Mundial lanzan alianza para fortalecer la atención primaria de salud en las Américas

PAHO, IDB and World Bank launch alliance to strengthen primary health care in the Americas

Oscar Reyes

4 Dec 2023

PAHO, IDB and World Bank launch alliance to strengthen primary health care in the Americas

Oscar Reyes

4 Dec 2023

1 year 4 months ago

Health – Dominican Today

1 in 10 children suffers from some type of disability, according to UNICEF

Santo Domingo.- Around 15% of the global population, or at least one billion people, live with some form of disability. This statistic includes nearly 240 million children, with a significant portion in Latin America and the Caribbean, where approximately 19.1 million children and adolescents have disabilities.

Santo Domingo.- Around 15% of the global population, or at least one billion people, live with some form of disability. This statistic includes nearly 240 million children, with a significant portion in Latin America and the Caribbean, where approximately 19.1 million children and adolescents have disabilities. However, 70% of school-age children and adolescents with disabilities in this region do not attend school. The Convention on the Rights of Persons with Disabilities, endorsed by the Dominican Republic, aims to ensure equal rights and freedoms for children with disabilities.

In the Dominican Republic, UNICEF highlights that one in ten children between 2 and 17 years old has a disability. The situation is more acute among the 5-17 age group, with 11.3% having a disability. Carlos Carrera, UNICEF’s country representative, points out that these children and their families face numerous barriers, including negative societal attitudes, lack of supportive policies, and limited educational and economic opportunities.

To address these challenges, significant initiatives have been undertaken in the Dominican Republic. In December 2022, 500 families with disabled children received a social protection bonus, spearheaded by First Lady Raquel Arbaje. This effort aims to ensure equal rights for these children and adolescents. Despite such measures, families like Antonia Peguero’s, who has a son with Down syndrome, still face hardships due to economic realities and high living costs.

Efforts to promote inclusive education are underway, with the Ministry of Education and UNICEF implementing pilot projects to transform education services for inclusive learning. This initiative involves the development of a National Inclusive Education Model to enhance inclusive education services in regular and special schools. UNICEF calls for societal change to overcome prejudices and eliminate barriers, ensuring inclusion for all children and adolescents with disabilities.

1 year 4 months ago

Health

Health | NOW Grenada

International Day of Persons with Disabilities

“The Ministry encourages the public to support these activities and assist in creating awareness to foster a more inclusive, supportive, and progressive environment for all our citizens with disabilities”

1 year 4 months ago

Health, PRESS RELEASE, gis, international day of persons with disabilities, ministry of education, st andrew’s school for special education, st george’s school for special education, victoria school for special education

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

AbbVie to acquire ImmunoGen, including its flagship cancer therapy Elahere

North Chicago, Ill.: AbbVie Inc. and ImmunoGen, Inc. have announced a definitive agreement under which AbbVie will acquire ImmunoGen, and its flagship cancer therapy ELAHERE (mirvetuximab soravtansine-gynx), a first-in-class antibody-drug conjugate (ADC) approved for platinum-resistant ovarian cancer (PROC).

The acquisition accelerates AbbVie's commercial and clinical presence in the solid tumor space. Additionally, ImmunoGen's follow-on pipeline of promising next-generation ADCs further complements AbbVie's ADC platform and existing programs.

Under the terms of the transaction, AbbVie will acquire all outstanding shares of ImmunoGen for $31.26 per share in cash. The transaction values ImmunoGen at a total equity value of approximately $10.1 billion. The boards of directors of both companies have approved the transaction. This transaction is expected to close in the middle of 2024, subject to ImmunoGen shareholder approval, regulatory approvals, and other customary closing conditions.

"The acquisition of ImmunoGen demonstrates our commitment to deliver on our long-term growth strategy and enables AbbVie to further diversify our oncology pipeline across solid tumors and hematologic malignancies," said Richard A. Gonzalez, chairman and chief executive officer, AbbVie. "Together, AbbVie and ImmunoGen have the potential to transform the standard of care for people living with cancer."

ImmunoGen's oncology portfolio has the potential to help drive long-term revenue growth for AbbVie's oncology franchise. Ovarian cancer is the leading cause of death from gynecological cancers in the U.S. ELAHERE is the first targeted medicine to show meaningful survival benefit in PROC. As a fast-growing solid tumor therapy, ELAHERE provides AbbVie with a potential multi-billion-dollar on-market medicine with expansion opportunities in earlier lines of therapy and larger segments of the ovarian cancer market.

"With global commercial infrastructure and deep clinical and regulatory expertise, AbbVie is the right company to accelerate geographic and label expansion, and realize the full potential of ELAHERE as the first and only ADC approved in ovarian cancer," said Mark Enyedy, president and chief executive officer, ImmunoGen. "The addition of ImmunoGen's pipeline, platform, and expertise to AbbVie's oncology portfolio is an exciting opportunity for the combined companies to advance innovation in ADCs. This transaction is the culmination of our 40-year commitment to develop and deliver the next-generation of ADCs and more good days for people living with cancer."

ELAHERE is a first-in-class ADC targeting folate receptor alpha (FRα) with a maytansinoid payload DM4, a potent tubulin inhibitor designed to kill the targeted cancer cells. ELAHERE received U.S. Food and Drug Administration (FDA) accelerated approval in 2022 for the treatment of adult patients with FRα positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received one to three prior systemic treatment regimens. The positive Phase 3 results from the MIRASOL confirmatory trial will support a Marketing Authorization Application (MAA) to the European Union and a supplemental Biologic License Application (sBLA) submission to the U.S. FDA in order to gain full approval. Ongoing clinical development programs are underway to expand into earlier lines of therapy and enter other large patient segments of the ovarian market over the next 5-10 years.

ImmunoGen's follow-on pipeline of promising next-generation ADCs expands AbbVie's growing oncology pipeline of potentially transformative programs across multiple different solid tumors and hematologic malignancies. ImmunoGen's Phase 1 asset, IMGN-151, is a next-generation anti-FRα ADC for ovarian cancer with the potential for expansion into other solid tumor indications. Pivekimab sunirine, currently in Phase 2, is an anti-CD123 ADC targeting blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare blood cancer, which was granted FDA breakthrough therapy designation for the treatment of relapsed/refractory BPDCN.

AbbVie will acquire all outstanding ImmunoGen common stock for $31.26 per share in cash. The proposed transaction is subject to customary closing conditions, including receipt of regulatory approvals and approval by ImmunoGen stockholders. The proposed transaction is expected to be accretive to diluted earnings per share (EPS) beginning in 2027.

Read also: Abbvie executive Patrick Horber appointed as Novartis's President, International

1 year 4 months ago

News,Oncology,Oncology News,Industry,Pharma News,Latest Industry News

Pages